{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:08:37Z","timestamp":1793210917742,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Project of Modern Hospital Management and Development Institute, Nanjing University & Aid Project of Nanjing Drum Tower Hospital Health, Education & Research Foundation","award":["(NDYG2021044)"],"award-info":[{"award-number":["(NDYG2021044)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s40121-023-00812-2","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T05:01:46Z","timestamp":1683176506000},"page":"1579-1592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacist-Driven Dosing Services and Pharmaceutical Care Increase Probability of Teicoplanin Target Concentration Attainment and Improve Clinical and Economic Outcomes in Non-Critically Ill Patients"],"prefix":"10.1007","volume":"12","clinical-trial-number":[{"clinical-trial-number":"chictr2000033521","registry":"10.18810\/chictr"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6947-1869","authenticated-orcid":false,"given":"Dayu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingkai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoshi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"812_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5863\/1551-6776-27.4.340","volume":"27","author":"SW Hovey","year":"2022","unstructured":"Hovey SW, Jacobson JL, Welsh KM, Vu BN. Implementation of a pharmacist-driven vancomycin and aminoglycoside dosing service in a pediatric hospital. J Pediatr Pharmacol Ther. 2022;27:340\u20136. https:\/\/doi.org\/10.5863\/1551-6776-27.4.340.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"812_CR2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1177\/1060028015587900","volume":"49","author":"KA Marquis","year":"2015","unstructured":"Marquis KA, DeGrado JR, Labonville S, Kubiak DW, Szumita PM. Evaluation of a pharmacist-directed vancomycin dosing and monitoring pilot program at a tertiary academic medical center. Ann Pharmacother. 2015;49:1009\u201314. https:\/\/doi.org\/10.1177\/1060028015587900.","journal-title":"Ann Pharmacother"},{"key":"812_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5414\/CP202274","volume":"53","author":"N Masuda","year":"2015","unstructured":"Masuda N, Maiguma T, Komoto A, Haruki Y, Sugiyama T, Kondo S, Teshima D. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin. Int J Clin Pharmacol Ther. 2015;53:284\u201391. https:\/\/doi.org\/10.5414\/CP202274.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"812_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4140\/TCP.n.2016.505","volume":"31","author":"AP Smith","year":"2016","unstructured":"Smith AP, Millares-Sipin CA, James M, Cohen H. Impact of a pharmacist-initiated vancomycin monitoring program. Consult Pharm. 2016;31:505\u201310. https:\/\/doi.org\/10.4140\/TCP.n.2016.505.","journal-title":"Consult Pharm"},{"key":"812_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000440607","volume":"61","author":"H Momattin","year":"2016","unstructured":"Momattin H, Zogheib M, Homoud A, Al-Tawfiq JA. Safety and outcome of pharmacy-led vancomycin dosing and monitoring. Chemotherapy. 2016;61:3\u20137. https:\/\/doi.org\/10.1159\/000440607.","journal-title":"Chemotherapy"},{"key":"812_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.annemergmed.2021.11.031","volume":"79","author":"K Kooda","year":"2022","unstructured":"Kooda K, Canterbury E, Bellolio F. Impact of pharmacist-led antimicrobial stewardship on appropriate antibiotic prescribing in the emergency department: a systematic review and meta-analysis. Ann Emerg Med. 2022;79:374\u201387. https:\/\/doi.org\/10.1016\/j.annemergmed.2021.11.031.","journal-title":"Ann Emerg Med"},{"key":"812_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.mcna.2018.05.009","volume":"102","author":"DM Parente","year":"2018","unstructured":"Parente DM, Morton J. Role of the pharmacist in antimicrobial stewardship. Med Clin North Am. 2018;102:929\u201336. https:\/\/doi.org\/10.1016\/j.mcna.2018.05.009.","journal-title":"Med Clin North Am"},{"key":"812_CR8","first-page":"2198","volume":"43","author":"CV Fletcher","year":"1986","unstructured":"Fletcher CV, Giese RM, Rodman JH. Pharmacist interventions to improve prescribing of vancomycin and tobramycin. Am J Hosp Pharm. 1986;43:2198\u2013201.","journal-title":"Am J Hosp Pharm"},{"key":"812_CR9","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.2146\/ajhp040555","volume":"62","author":"CA Bond","year":"2005","unstructured":"Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy. Am J Health Syst Pharm. 2005;62:1596\u2013605. https:\/\/doi.org\/10.2146\/ajhp040555.","journal-title":"Am J Health Syst Pharm"},{"key":"812_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/jac\/dkl017","volume":"57","author":"CG Gemmell","year":"2006","unstructured":"Gemmell CG, Edwards DI, Fraise AP, Gould FK, Ridgway GL, Warren RE, Joint Working Party of the British Society for Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother. 2006;57:589\u2013608. https:\/\/doi.org\/10.1093\/jac\/dkl017.","journal-title":"J Antimicrob Chemother"},{"key":"812_CR11","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1128\/AAC.00341-09","volume":"53","author":"S Svetitsky","year":"2009","unstructured":"Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother. 2009;53:4069\u201379. https:\/\/doi.org\/10.1128\/AAC.00341-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"812_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jac\/37.2.209","volume":"37","author":"MJ Wood","year":"1996","unstructured":"Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother. 1996;37:209\u201322. https:\/\/doi.org\/10.1093\/jac\/37.2.209.","journal-title":"J Antimicrob Chemother"},{"key":"812_CR13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/jac\/dkab499","volume":"77","author":"Y Hanai","year":"2022","unstructured":"Hanai Y, Takahashi Y, Niwa T, Mayumi T, Hamada Y, Kimura T, Matsumoto K, Fujii S, Takesue Y. Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J Antimicrob Chemother. 2022;77:869\u201379. https:\/\/doi.org\/10.1093\/jac\/dkab499.","journal-title":"J Antimicrob Chemother"},{"key":"812_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10156-006-0446-y","volume":"12","author":"M Sato","year":"2006","unstructured":"Sato M, Chida K, Suda T, Muramatsu H, Suzuki Y, Hashimoto H, et\u00a0al. Recommended initial loading dose of teicoplanin, established by therapeutic drug monitoring, and outcome in terms of optimal trough level. J Infect Chemother. 2006;12:185\u20139. https:\/\/doi.org\/10.1007\/s10156-006-0446-y.","journal-title":"J Infect Chemother"},{"key":"812_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/jac\/dkg147","volume":"51","author":"F Pea","year":"2003","unstructured":"Pea F, Brollo L, Viale P, Pavan F, Furlanut M. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose. J Antimicrob Chemother. 2003;51:971\u20135. https:\/\/doi.org\/10.1093\/jac\/dkg147.","journal-title":"J Antimicrob Chemother"},{"key":"812_CR16","doi-asserted-by":"publisher","first-page":"817401","DOI":"10.3389\/fphar.2022.817401","volume":"13","author":"L Shi","year":"2022","unstructured":"Shi L, Zhuang Z, Duan L, Zhu C, Xue H, Wang X, Xu X, Yuan Y, Shi L, Li J, Sun J, Liu X, Zhou Q, Lu J, Tang L. Dose optimization of teicoplanin for critically ill patients with renal dysfunction and continuous renal replacement therapy: experience from a prospective interventional study. Front Pharmacol. 2022;13:817401. https:\/\/doi.org\/10.3389\/fphar.2022.817401.","journal-title":"Front Pharmacol"},{"key":"812_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3389\/fphar.2020.00552","volume":"11","author":"L Gao","year":"2020","unstructured":"Gao L, Xu H, Ye Q, Li S, Wang J, Mei Y, Niu C, Kang T, Chen C, Wang Y. Population pharmacokinetics and dosage optimization of teicoplanin in children with different renal functions. Front Pharmacol. 2020;11:552. https:\/\/doi.org\/10.3389\/fphar.2020.00552.","journal-title":"Front Pharmacol"},{"key":"812_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1469-0691.2004.00747.x","volume":"10","author":"ES Darley","year":"2004","unstructured":"Darley ES, MacGowan AP. The use and therapeutic drug monitoring of teicoplanin in the UK. Clin Microbiol Infect. 2004;10:62\u20139. https:\/\/doi.org\/10.1111\/j.1469-0691.2004.00747.x.","journal-title":"Clin Microbiol Infect"},{"key":"812_CR19","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1136\/ejhpharm-2017-001307","volume":"25","author":"P Mas-Morey","year":"2018","unstructured":"Mas-Morey P, Ballesteros-Fern\u00e1ndez A, Sanmartin-Mestre E, Valle M. Impact of clinical pharmacist intervention on antimicrobial use in a small 164-bed hospital. Eur J Hosp Pharm. 2018;25:e46\u201351. https:\/\/doi.org\/10.1136\/ejhpharm-2017-001307.","journal-title":"Eur J Hosp Pharm"},{"issue":"2","key":"812_CR20","first-page":"1","volume":"2012","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO. Clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2012(2):1\u2013138.","journal-title":"Kidney Int Suppl"},{"key":"812_CR21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1177\/10600280221078123","volume":"56","author":"R Elajez","year":"2022","unstructured":"Elajez R, Abdallah I, Bakdach D, Shaat E, Osman E, Baraka M, Gergess R, Abdalla R, Al Hamoud E, Al Bakri M, Al SH. Thrombocytopenia associated with teicoplanin use: a retrospective observational study. Ann Pharmacother. 2022;56:1231\u20136. https:\/\/doi.org\/10.1177\/10600280221078123.","journal-title":"Ann Pharmacother"},{"key":"812_CR22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/hep.32689","volume":"77","author":"RJ Fontana","year":"2023","unstructured":"Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W, Navarro V. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2023;77:1036\u201365. https:\/\/doi.org\/10.1002\/hep.32689.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"812_CR23","doi-asserted-by":"publisher","first-page":"i73","DOI":"10.1093\/jac\/dkm163","volume":"60","author":"K Hand","year":"2007","unstructured":"Hand K. Antibiotic pharmacists in the ascendancy. J Antimicrob Chemother. 2007;60(Suppl 1):i73\u20136. https:\/\/doi.org\/10.1093\/jac\/dkm163.","journal-title":"J Antimicrob Chemother"},{"key":"812_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/antibiotics12020374","volume":"12","author":"K Jantarathaneewat","year":"2023","unstructured":"Jantarathaneewat K, Phodha T, Singhasenee K, Katawethiwong P, Suwantarat N, Camins B, Wongphan T, Rutjanawech S, Apisarnthanarak A. Impact of pharmacist-led multidisciplinary team to attain targeted vancomycin area under the curved monitoring in a tertiary care center in Thailand. Antibiotics (Basel). 2023;12:374. https:\/\/doi.org\/10.3390\/antibiotics12020374.","journal-title":"Antibiotics (Basel)"},{"key":"812_CR25","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1128\/AAC.34.11.2114","volume":"34","author":"WR Outman","year":"1990","unstructured":"Outman WR, Nightingale CH, Sweeney KR, Quintiliani R. Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses. Antimicrob Agents Chemother. 1990;34:2114\u20137. https:\/\/doi.org\/10.1128\/AAC.34.11.2114.","journal-title":"Antimicrob Agents Chemother"},{"key":"812_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2165\/00003088-200039030-00001","volume":"39","author":"AP Wilson","year":"2000","unstructured":"Wilson AP. Clinical pharmacokinetics of teicoplanin. Clin Pharmacokinet. 2000;39:167\u201383. https:\/\/doi.org\/10.2165\/00003088-200039030-00001.","journal-title":"Clin Pharmacokinet"},{"key":"812_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1159\/000189175","volume":"73","author":"RG Veldman","year":"1996","unstructured":"Veldman RG, van der Pijl JW, Claas FH. Teicoplanin-induced thrombocytopenia. Nephron. 1996;73:721\u20132. https:\/\/doi.org\/10.1159\/000189175.","journal-title":"Nephron"},{"key":"812_CR28","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s10096-021-04258-7","volume":"40","author":"AT Aslan","year":"2021","unstructured":"Aslan AT, Pashayev T, Da\u011f O, Akova M. Comparison of teicoplanin versus vancomycin in combination with piperacillin-tazobactam or meropenem for the risk of acute kidney injury. Eur J Clin Microbiol Infect Dis. 2021;40:1953\u201361. https:\/\/doi.org\/10.1007\/s10096-021-04258-7.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"812_CR29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/j.1875-9114.1992.tb04516.x","volume":"12","author":"RF Frye","year":"1992","unstructured":"Frye RF, Job ML, Dretler RH, Rosenbaum BJ. Teicoplanin nephrotoxicity: first case report. Pharmacotherapy. 1992;12:240\u20132.","journal-title":"Pharmacotherapy"},{"key":"812_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s11096-012-9642-2","volume":"34","author":"CS Moura","year":"2012","unstructured":"Moura CS, Prado NM, Belo NO, Acurcio FA. Evaluation of drug\u2013drug interaction screening software combined with pharmacist intervention. Int J Clin Pharm. 2012;34:547\u201352. https:\/\/doi.org\/10.1007\/s11096-012-9642-2.","journal-title":"Int J Clin Pharm"},{"key":"812_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.ahj.2009.07.034","volume":"158","author":"AV Ambardekar","year":"2009","unstructured":"Ambardekar AV, Fonarow GC, Hernandez AF, Pan W, Yancy CW, Krantz MJ. Get with the guidelines steering committee and hospitals. Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from get with the guidelines-heart failure (GWTG-HF). Am Heart J. 2009;158:644\u201352. https:\/\/doi.org\/10.1016\/j.ahj.2009.07.034.","journal-title":"Am Heart J"},{"key":"812_CR32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.cardfail.2013.02.002","volume":"19","author":"SK Milfred-Laforest","year":"2013","unstructured":"Milfred-Laforest SK, Chow SL, Didomenico RJ, Dracup K, Ensor CR, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL 2nd, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail. 2013;19:354\u201369. https:\/\/doi.org\/10.1016\/j.cardfail.2013.02.002.","journal-title":"J Card Fail"},{"key":"812_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00134-003-1705-3","volume":"29","author":"SL Kane","year":"2003","unstructured":"Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691\u20138. https:\/\/doi.org\/10.1007\/s00134-003-1705-3.","journal-title":"Intensive Care Med"},{"key":"812_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/archinte.168.7.687","volume":"168","author":"SL Koshman","year":"2008","unstructured":"Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168:687\u201394. https:\/\/doi.org\/10.1001\/archinte.168.7.687.","journal-title":"Arch Intern Med"},{"key":"812_CR35","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2015.09.025","volume":"66","author":"SP Dunn","year":"2015","unstructured":"Dunn SP, Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page RL 2nd, Bittner V, Walsh MN. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J Am Coll Cardiol. 2015;66:2129\u201339. https:\/\/doi.org\/10.1016\/j.jacc.2015.09.025.","journal-title":"J Am Coll Cardiol"},{"key":"812_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/phar.2083","volume":"38","author":"MD Anderegg","year":"2018","unstructured":"Anderegg MD, Gums TH, Uribe L, MacLaughlin EJ, Hoehns J, Bazaldua OV, Ives TJ, Hahn DL, Coffey CS, Carter BL. Pharmacist intervention for blood pressure control in patients with diabetes and\/or chronic kidney disease. Pharmacotherapy. 2018;38:309\u201318. https:\/\/doi.org\/10.1002\/phar.2083.","journal-title":"Pharmacotherapy"},{"key":"812_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.21037\/atm-22-1172","volume":"10","author":"Y Tong","year":"2022","unstructured":"Tong Y, Sun J, Xin W, Chen L, Kong S, Mi X, Feng Y, Jin W, Wu Y, Ding H, Fang L. Pharmacist-led standardization of total parenteral nutrition improves postoperative nutritional status in colorectal cancer patients. Ann Transl Med. 2022;10:339. https:\/\/doi.org\/10.21037\/atm-22-1172.","journal-title":"Ann Transl Med"},{"key":"812_CR38","doi-asserted-by":"publisher","first-page":"104568","DOI":"10.1016\/j.ijmedinf.2021.104568","volume":"155","author":"E Cuvelier","year":"2021","unstructured":"Cuvelier E, Robert L, Musy E, Rousseli\u00e8re C, Marcilly R, Gautier S, Odou P, Beuscart JB, D\u00e9caudin B. The clinical pharmacist\u2019s role in enhancing the relevance of a clinical decision support system. Int J Med Inf. 2021;155:104568. https:\/\/doi.org\/10.1016\/j.ijmedinf.2021.104568.","journal-title":"Int J Med Inf"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00812-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-023-00812-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00812-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T01:01:31Z","timestamp":1702342891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-023-00812-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1007\/s40121-023-00812-2","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,4]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}